Two Onc Docs Metastatic Prostate Cancer 2023 UPDATE
Sep 18, 2023
Exploring cutting-edge therapies for metastatic prostate cancer including triplet and doublet therapies, radium-223, Lutetium-LU-177 targeted therapy, and genetic testing significance with Drimline testing standards. Also, discussing the importance of supportive care, dental clearance, and monitoring PSA levels for personalized treatment protocols in 2023.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Advanced Treatment Approaches for Prostate Cancer
02:09 • 6min
In-depth Discussion on Metastatic Prostate Cancer Treatments and Toxicities
08:22 • 3min
Genetic Testing and Treatment Options for Prostate Cancer in 2023
10:58 • 2min
Supportive Care and Treatment Protocols for Prostate Cancer Patients
12:31 • 3min